Literature DB >> 18005691

The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

Theodore C Pierson1, Qing Xu, Steevenson Nelson, Theodore Oliphant, Grant E Nybakken, Daved H Fremont, Michael S Diamond.   

Abstract

Antibody binding to the icosahedral arrangement of envelope proteins on the surface of flaviviruses can result in neutralization or enhancement of infection. We evaluated how many antibodies must bind to a given epitope on West Nile virus (WNV) to achieve neutralization. The most potent monoclonal antibodies (mAbs) block infection at concentrations that result in low occupancy of accessible sites on the virion, with neutralization occurring when as few as 30 of 180 envelope proteins are bound. In contrast, weakly neutralizing mAbs recognize fewer sites on the virion and require almost complete occupancy to inhibit WNV infection. For all mAbs studied, enhancement of infection is possible in cells bearing activating Fc-gamma receptors when the number of mAbs docked to the virion is not sufficient for neutralization. Thus, neutralization is best described by a model requiring "multiple hits" with the cumulative functional outcome determined by interplay between antibody affinity and epitope accessibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005691      PMCID: PMC2656919          DOI: 10.1016/j.chom.2007.03.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  64 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

Authors:  S Bhardwaj; M Holbrook; R E Shope; A D Barrett; S J Watowich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.

Authors:  A K Falconar
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

Review 4.  A model for neutralization of viruses based on antibody coating of the virion surface.

Authors:  D R Burton; E O Saphire; P W Parren
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

5.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

6.  The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin).

Authors:  Carl W Davis; Lisa M Mattei; Hai-Yen Nguyen; Camilo Ansarah-Sobrinho; Robert W Doms; Theodore C Pierson
Journal:  J Biol Chem       Date:  2006-09-25       Impact factor: 5.157

7.  Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

Authors:  John D Morrey; Venkatraman Siddharthan; Aaron L Olsen; Grant Y Roper; Hong Wang; Thomas J Baldwin; Scott Koenig; Syd Johnson; Jeffrey L Nordstrom; Michael S Diamond
Journal:  J Infect Dis       Date:  2006-09-22       Impact factor: 5.226

8.  Crystal structure of the West Nile virus envelope glycoprotein.

Authors:  Grant E Nybakken; Christopher A Nelson; Beverly R Chen; Michael S Diamond; Daved H Fremont
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

9.  Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

Authors:  Theodore Oliphant; Grant E Nybakken; Michael Engle; Qing Xu; Christopher A Nelson; Soila Sukupolvi-Petty; Anantha Marri; Bat-El Lachmi; Udy Olshevsky; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

10.  Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

Authors:  R S Lanciotti; J T Roehrig; V Deubel; J Smith; M Parker; K Steele; B Crise; K E Volpe; M B Crabtree; J H Scherret; R A Hall; J S MacKenzie; C B Cropp; B Panigrahy; E Ostlund; B Schmitt; M Malkinson; C Banet; J Weissman; N Komar; H M Savage; W Stone; T McNamara; D J Gubler
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

View more
  163 in total

1.  Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.

Authors:  Michelle C Sabo; Vincent C Luca; Stuart C Ray; Jens Bukh; Daved H Fremont; Michael S Diamond
Journal:  Virology       Date:  2011-11-12       Impact factor: 3.616

2.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.

Authors:  Erin Mehlhop; Camilo Ansarah-Sobrinho; Syd Johnson; Michael Engle; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

3.  Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.

Authors:  Feng Long; Michael Doyle; Estefania Fernandez; Andrew S Miller; Thomas Klose; Madhumati Sevvana; Aubrey Bryan; Edgar Davidson; Benjamin J Doranz; Richard J Kuhn; Michael S Diamond; James E Crowe; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-14       Impact factor: 11.205

4.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 5.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

Review 6.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

7.  Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis.

Authors:  Steevenson Nelson; Subhajit Poddar; Tsai-Yu Lin; Theodore C Pierson
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

Authors:  Gregory D Gromowski; Nicholas D Barrett; Alan D T Barrett
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

10.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.

Authors:  Per Johan Klasse
Journal:  Virology       Date:  2007-09-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.